HUDSON, N.Y., April 26, 2017 -- Taconic Biosciences, a global leader in genetically engineered mouse models and associated services and the only commercial provider of germ-free mice, announced that effective April 26, 2017 they will expand their microbiome product and services platform to include custom Fecal Microbiota Transplantation (FMT) services. To support these new FMT services, Taconic will also offer custom germ-free derivations using either client mouse models, Taconic’s commercial offerings, or mice sourced from third parties.
This new FMT service offering capitalizes on Taconic’s decades of microbiome experience, existing portfolio of germ-free offerings including Germ-Free C57BL/6NTac and Swiss Webster mice, and ability to derive germ-free animals from Taconic’s large catalog of mutant mice or client-provided models.
Dr. Alexander Maue, Taconic Biosciences’ portfolio director for microbiome products and services, commented, “The germ-free mouse is the ideal substrate to evaluate the properties of complex or defined gut microbiota following FMT. Axenic mice transplanted with donor microbiota can be used to assess the effects of gut bacteria on a wide range of biological systems, including but not limited to, immunity, neurodegenerative diseases, obesity, and diabetes.”
“Our custom germ-free derivation services enable Taconic to generate initial cohorts of up to 40 germ-free animals, allowing researchers to generate rapid study cohorts.”
Prior to the start of any custom FMT project or germ-free derivation service, Taconic consults with the client to understand their research goals and develop a strategy for project execution. A dedicated Project Manager will keep clients updated throughout the project. Following FMT, Taconic offers a range of husbandry options to accommodate studies of all sizes and durations including options for isolators and state of the art individually ventilated cages (IVCs).
In addition to providing microbiome products and services, Taconic also is a fully-licensed provider of rodent model generation services and has twenty years of model design experience. Complimenting this expertise is Taconic’s unique capability of providing a seamless transition from model design to breeding and colony management, thus offering customers a complete solution. These scientific services include acquiring or generating, importing, licensing, breeding, testing, preparing, and distributing genetically engineered models to any location worldwide.
To learn more about Taconic’s microbiome products and services, please contact Taconic Biosciences at 1-888-TACONIC (888-822-6642) in the US, +45 70 23 04 05 in Europe or at [email protected].
About Taconic Biosciences, Inc.
Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic helps biotechnology companies and institutions acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, precision research mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.
Media Contact: Kelly Owen Grover Director of Marketing Communications (518) 697-3824 [email protected]


Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings
Australia Targets Meta, Google, and TikTok With New News Payment Tax Proposal
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Advantest Stock Falls on Weak Outlook Despite Strong AI-Driven Results
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth
Google Secures Pentagon AI Deal for Classified Projects 



